MoneyWorks4Me

The sales slipped to Rs. 1119.40 millions for the March 2022 quarter as against Rs. 1228.80 millions during the year-ago period.A slender decline of -7.84% was recorded to Rs. 290.20  millions from Rs. 314.90 millions in the corresponding previous quarter.A decline of 486.70 millions was observed in the OP in the quarter ended March 2022 from 506.40 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1119.40 1228.80 -8.90 5280.60 4826.80 9.40 5280.60 4826.80 9.40
Other Income 102.60 73.60 39.40 565.50 186.20 203.71 565.50 186.20 203.71
PBIDT 486.70 506.40 -3.89 2761.70 2325.50 18.76 2761.70 2325.50 18.76
Interest 0.20 0.30 -33.33 0.90 1.70 -47.06 0.90 1.70 -47.06
PBDT 486.50 506.10 -3.87 2760.80 2323.80 18.81 2760.80 2323.80 18.81
Depreciation 69.50 59.70 16.42 257.70 224.40 14.84 257.70 224.40 14.84
PBT 417.00 446.40 -6.59 2503.10 2099.40 19.23 2503.10 2099.40 19.23
TAX 126.80 131.50 -3.57 624.40 537.10 16.25 624.40 537.10 16.25
Deferred Tax 0.10 0.30 -66.67 8.20 -11.70 -170.09 8.20 -11.70 -170.09
PAT 290.20 314.90 -7.84 1878.70 1562.30 20.25 1878.70 1562.30 20.25
Equity 151.60 151.30 0.20 151.60 151.30 0.20 151.60 151.30 0.20
PBIDTM(%) 43.48 41.21 5.50 52.30 48.18 8.55 52.30 48.18 8.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..